Eton Pharmaceuticals (ETON) Total Liabilities (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Total Liabilities of $66.0 million for Q4 2025, down 18.95% sequentially from $81.4 million in Q3 2025, and up 27.59% YoY from $51.7 million in Q4 2024.
Eton Pharmaceuticals (ETON) Total Liabilities (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Total Liabilities for 9 years, with the latest figure at $66.0 million in Q4 2025.
- Quarterly Total Liabilities rose 27.59% year-over-year to $66.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $66.0 million (up 27.59% YoY) and the FY2025 annual result came in at $66.0 million, up 27.59% from the prior year.
- Total Liabilities retreated to $66.0 million in Q4 2025 per ETON's latest filing, from $81.4 million in the prior quarter.
- Over five years, Total Liabilities peaked at $81.4 million in Q3 2025 and troughed at $9.2 million in Q2 2021.
- A 5-year average of $26.5 million and a median of $14.4 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities slipped 7.7% in 2021, then surged 323.26% in 2025.
- Over 5 years, Total Liabilities stood at $9.8 million in 2021, then grew by 21.53% to $12.0 million in 2022, then jumped by 36.07% to $16.3 million in 2023, then jumped by 217.87% to $51.7 million in 2024, then gained by 27.59% to $66.0 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $66.0 million, $81.4 million, and $77.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 69.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.22 Mn |
| Dec 31, 2025 | 65.96 Mn |
| Sep 30, 2025 | 81.38 Mn |
| Jun 30, 2025 | 77.72 Mn |
| Mar 31, 2025 | 59.58 Mn |
| Dec 31, 2024 | 51.70 Mn |
| Sep 30, 2024 | 19.86 Mn |
| Jun 30, 2024 | 18.36 Mn |
| Mar 31, 2024 | 15.30 Mn |
| Dec 31, 2023 | 16.26 Mn |
| Sep 30, 2023 | 14.63 Mn |
| Jun 30, 2023 | 14.21 Mn |
| Mar 31, 2023 | 12.69 Mn |
| Dec 31, 2022 | 11.95 Mn |
| Sep 30, 2022 | 10.34 Mn |
| Jun 30, 2022 | 9.80 Mn |
| Mar 31, 2022 | 9.81 Mn |
| Dec 31, 2021 | 9.84 Mn |
| Sep 30, 2021 | 10.95 Mn |
| Jun 30, 2021 | 9.17 Mn |